Background. Intrahepatic biliary fibrosis, as seen with cholestatic liver injuries such as biliary atresia, is mechanistically distinct from fibrosis caused by hepatocyte toxicity. We previously demonstrated the expansion of cells expressing the stem/progenitor cell marker Prominin-1, within regions of developing fibrosis in biliary atresia. Thus, we hypothesized that Prominin-1 expression is biliary fibrosis-specific. Methods. Gene expression of Prominin-1 was analyzed in adult mice undergoing either cholestatic bile duct ligation or hepatotoxic carbon tetrachloride administration by quantitative polymerase chair reaction. Lineage tracing of Prominin-1-expressing cells and Collagen-1a-expressing cells was performed after bile duct ligation in Prominin-1 cre-ert2Àlacz ;Gfp lsl and Collagen-1a Gfp transgenic mice, respectively.
Results. Prominin-1 expression increased significantly after bile duct ligation compared with sham (6.6 ± 0.9-fold change at 2 weeks, P < .05) but not with carbon tetrachloride (À0.7 ± 0.5-fold change, not significant). Upregulation of Prominin-1 was observed histologically throughout the liver as early as 5 days after bile duct ligation in Prominin-1 cre-ert2Àlacz mice by LacZ staining in nonhepatocyte cells. Lineage tracing of Prominin-1-expressing cells labeled prior to bile duct ligation in Prominin-1 cre-ert2Àlacz ;Gfp lsl mice, demonstrated increasing colocalization of GREEN FLUORESCENT PROTEIN with biliary marker CYTOKERATIN-19 within ductular reactions up to 5 weeks after bile duct ligation consistent with biliary transdifferentiation. In contrast, rare colocalization of GREEN FLUORESCENT PROTEIN with mesenchymal marker a-SMOOTH MUSCLE ACTIN 1 Although operative bypass of the atretic extrahepatic biliary tree is essential for survival, the extent and progression of intrahepatic biliary fibrosis are key determinants of transplant-free survival. 2 Thus, characterizing the pathogenesis of biliary fibrosis associated with biliary atresia remains essential in efforts to impact survival for infants with BA.
Prominin-1 (Prom-1), or CD133, is a pentatransmembrane glycoprotein expressed by collagen-producing hepatic stellate cells and portal fibroblasts as well as by stem/progenitor cells in a variety of tissues including the liver. 3 The function of Prominin-1 is unknown, although several studies indicate its role in maintaining the topology of the plasma membrane, in effect regulating the state of cellular differentiation. [4] [5] [6] Prom-1-expressing hepatic progenitor cells possess great regenerative and malignant potential 7 and may contribute to the populating of tissue-engineered liver constructs. 8 We also have previously demonstrated the expansion of a population of cells expressing prom-1 within periportal regions of evolving biliary fibrosis in both the rodent rotavirus model of BA as well as in infants with BA. 9 These cells exhibit characteristics of progenitor cells with expression of both epithelial and mesenchymal markers such as CYTOKERATIN-19 (CK19) and a-SMOOTH MUSCLE ACTIN (aSMA), respectively. Thus, we hypothesized that Prom-1-expressing cell expansion is a biliary fibrosis-specific phenomenon. To test this hypothesis, we compared Prom-1 gene expression patterns in adult mouse models of cholestasis/biliary fibrosis by bile duct ligation (BDL) and hepatocyte-specific carbon tetrachloride (CCl 4 ) injury, as well as lineage tracing to demonstrate the progenitor cell nature of Prom-1-expressing cells.
METHODS
Animal experiments. Six-week old wildtype C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) were injected subcutaneously with either CCl 4 (1 mL/kg body weight) in mineral oil (1:3 dilution), or control, every third day. Six-week old wildtype, Prom-1 cre-ert2-lacz ;Gfp lsl (both from Jackson Laboratories), or Col1a
Gfp (a gift from David Brenner, University of California San Diego) 10 transgenic mice underwent BDL as previously described. Thereafter, all mice were recovered and fed standard rodent chow and water ad libitum. With either liver injury model, mice were euthanized up to 6 weeks postinjury for collection of liver samples. All animal procedures were approved by the Children's Hospital Los Angeles Saban Research Institute's or the University of Southern California's Institutional Animal Care and Use Committee.
Immunohistochemistry. Livers were fixed in 4% paraformaldehyde (Poly Sciences Inc, Warrington, PA), embedded in paraffin, and then sectioned. Immunofluorescence imaging was performed as previously described 12 using primary antibodies listed in Supplemental Table I and secondary antibodies conjugated either with anti-mouse Cy3/Cy5, anti-rat Cy3/Cy5, or anti-rabbit Cy3/ Cy5 (Jackson Immuno Research Lab, West Grove, PA). Images were acquired using a Leica DM5500B immunofluorescence microscope with Leica Suite Advanced Fluorescence (LAS AF) 6000 software (Wetzlar, Germany) or a LSM700 confocal system with ZEN software (Carl Zeiss Microimaging, Thornwood, NY). Bright field images were acquired using a Leica DM1000 (DFC290) microscope interfaced with Leica Application Suite, version 2.7.1R1 (Leica Microsystems, Switzerland). Sirius red staining was performed as previously described. 9 LacZ staining. Liver tissue was fixed with 2% paraformaldehyde at 48C overnight, then incubated in 20% sucrose at 48C overnight and finally embedded in optimum cutting temperature. Frozen sections were washed in phosphate buffered solution (PBS) for 5 minutes and incubated in b-gal substrate (1 mg/mL X-gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40 in PBS) in the dark overnight at 378C. Sections were washed in PBS for 5 minutes and counterstained with eosin. ImageJ (National Institutes of Health, Bethesda, MD) was used to quantify cell positivity for LacZ staining.
Quantitative polymerase chain reaction. Total RNA was isolated from whole and nonparenchymal cell fractions of snap-frozen mouse liver tissues and fluorescence activated cell sorting-sorted cells using the Qiagen RNA isolation kit (Qiagen, Valencia, CA). Complementary DNA synthesis was performed using iScript Reverse Transcription Supermix (Bio-Rad, Irvine, CA), and quantitative real-time polymerase chain reaction (qPCR) was performed as previously described, 11,13 using intron-spanning and genespecific primers and probes designed using the Roche Universal Probe Library Assay Design Center (Roche, Basel, Switzerland; Supplemental Table II for primer sequences and probes).
RESULTS
Prominin-1 expression increases after BDL but not after CCl 4 induced liver injury. We previously reported the emergence and expansion of Prom-1-expressing cells associated with evolving biliary fibrosis due to biliary atresia. 9 To further explore this observation, we compared cholestatic BDL with hepatotoxic CCl 4 up to 6 weeks postinjury. Notable in both models of liver injury, there is significant destruction of liver parenchymal with loss of hepatocytes within lobules with loss of cellular definition and nuclear pyknosis, even without hematoxylin counterstaining (eosin only ; Fig 1, A) . By Sirius red staining, we observed comparable progression of fibrosis in both models (Fig 1, A) . Analysis of gene expression profiles demonstrated an increase in Prom-1 expression prior to 3 weeks post-BDL 6.6 ± 0.9 fold (P < .05) weeks and a 12 ± 4-fold (P < .05) after 3 weeks post-BDL (Fig 1, B) . In contrast, there was no observable change in Prom-1 expression with CCl 4 treatment (À0.7 ± 0.5-fold change, not significant). These data suggest a biliary-fibrosis specific upregulation of Prom-1.
Spatial localization of Prom-1 expression was then performed by LacZ staining (eosin counterstain only) of livers from Prom-1 cre-ert2-nlacz mice 5 days after BDL, where b-galactosidase expression marks active expression of Prom-1. Rare cells positive for LacZ staining were observed 5 days after sham operation (Fig 2, A) . In contrast, 5 days after BDL, there were significantly more cells positive for LacZ within periportal regions near bile ducts and also within the liver parenchyma, along sinusoids where hepatic stellate cells reside (8.6 ± 1.2 vs 37.2 ± 8.8, unpaired t test, P < .05; Fig 2, B and C). These data are consistent with the observed upregulation of prom-1 expression by qPCR (Fig 1, B) .
Cell fate of Prom-1-expressing cells after bile duct ligation. In order to determine if prom-1-expressing cells transdifferentiate during biliary fibrosis, we crossed Prom-1 cre-ert2-lacz mice with Gfp lsl mice. Tamoxifen was administered to 4-week old Prom-1 creert2;Gfp lsl mice 3 weeks prior to BDL in order to induce expression of Prom-1-expressing cellspecific Cre-driven recombination to express green fluorescent protein (GFP) permanently in their subsequent progeny. Three weeks after BDL, CK19 positive (pos) ductular reactions were observed in the periportal regions of hepatic lobules; few CK19 pos cells were copositive for GFP, indicating derivation from cells that were originally expressing Prom-1 at the time of tamoxifen administration (Fig 3) . Two weeks later, at 5 weeks post-BDL, nearly all cells in CK19 pos ductular reactions were GFP pos . These data suggest that over time, ductular reactions increasingly derive from Prom-1-expressing precursor cells.
Copositivity of GFP with a-smooth muscle actin (aSMA) also was noted in rare fibroblast-like cells (Fig 4) . (Fig 5) . Collectively these data suggest that Prom-1-expressing progenitor cells transdifferentiate predominantly into biliary ductular reactive cells and contribute minimally to the pool of collagen-producing myofibroblasts. Our data also suggest that ductular reactions which derive from Prom-1-expressing progenitors, lose their expression of Prom-1 over time.
DISCUSSION
In this study, we demonstrated a biliary fibrosisspecific upregulation of Prom-1 expression after BDL. We further demonstrated evidence via histologic lineage tracing, that ductular reactions within regions of evolving biliary fibrosis are increasingly comprised of cells deriving from Prom-1-expressing progenitor cells. In contrast, we observed only a minimal contribution of Prom-1-expressing cells to the pool of collagen producing myofibroblasts. Collectively, these data support the concept that Prom-1-expressing progenitor cells transdifferentiate primarily into biliary ductular reactions, within regions of evolving biliary fibrosis, adjacent to collagen-expressing cells.
The underlying pathophysiology of biliary fibrosis, secondary to cholestatic liver injury, remains undetermined. Using Col1a
Gfp mice, Iwaisako et al 10 reported that during early biliary fibrogenesis after BDL, aPFs, which reside in periportal regions where biliary fibrogenesis originates, contribute more significantly to the population of collagen-producing myofibroblasts than hepatic stellate cells (HSCs), which reside in the hepatic sinusoids throughout the hepatic lobule. Lua et al, 11 however, observed that activated HSCs, not aPFs, are the predominant myofibroblasts after BDL. Regardless of which cell population contributes most to the pool of collagenproducing myofibroblasts, our observations are consistent with Prom-1-expressing progenitor cells transdifferentiating into cells comprising biliary ductular reactions within regions of biliary fibrosis during cholestatic liver injury. Furthermore, our data indicate that ductular reactions may lose expression of Prom-1 over time after BDL. It is unclear how significant any downregulation of prom-1 in developing ductular reactions is, but we posit that this may be in response to terminal differentiation of a progenitor cell population.
The significance of Prom-1-expressing biliary progenitor cell transdifferentiation remains unanswered by this study. There is evidence, however, that Prom-1-expressing hepatic progenitor cells may contribute to biliary fibrosis. Rountree et al 14 demonstrated that Prom-1-expressing cells comprise ductular reactions that develop in the rodent model of cholestasis/biliary fibrosis induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet.
14 Moreover, expansion of a single PROM1 pos CD45 neg hepatic progenitor cell clone isolated from liver tumors from Albumin Cre ;Pten loxp mice could be passaged multiply maintaining an epithelial progenitor cell phenotype. However, spontaneous transformation of a subset of these PROM-1 pos cells was associated with a more mesenchymal, fibroblastic phenotype, and functionally with tumor metastases. 15 In this study, lineage tracing of Prom-1-expressing precursor cells demonstrated qualitatively a large contribution to biliary ductular reactions within regions of collagen deposition. Although the direct contribution of Prom-1-expressing progenitors to collagen-producing myofibroblasts was small, a role in biliary fibrosis cannot be excluded. Indeed, Nadler et al 16 demonstrated that cells within ductular reactions of biliary fibrosis in the murine model of biliary atresia express Integrina v b 6 , a key mediator in the activation of profibrogenic transforming growth factor-b. 16 We posit that the expression of Prom-1 may contribute to biliary fibrogenesis potentially, in part, through promotion of Transforming Growth Factor-b signaling activation in downstream progeny, but further analysis is required to validate this potential link.
We had previously demonstrated colocalization of prom-1 and aSMA during fibrogenesis associated with biliary atresia. 9 In this study, we demonstrated upregulation of Prom-1 gene expression within the liver after BDL but not with CCl4 injury. Interestingly, by LacZ staining of Prom-1 cre-ert2-nlacz mice 5 days after BDL, we observed Prom-1 expression not only within the periportal regions of the hepatic lobule but also along hepatic sinusoids in a pattern consistent with that of HSCs. This spatial pattern of expression is not evident with lineage tracing of Prom-1-expressing cells after BDL, suggesting not only transdifferentiation of Prom-1-expressing progenitor cells, but also upregulation of Prom-1 expression in existing HSCs. Further analysis is required to first determine if indeed both quiescent HSCs and portal fibroblasts upregulate Prom-1 expression after BDL and second to determine the significance of Prom-1 expression during fibrogenesis.
In this study, we provide qualitative, histologic evidence of Prom-1-expressing cell transdifferentiation during fibrogenesis associated with cholestasis after bile duct ligation. It is likely that there is significantly more biliary ductular transdifferentiation compared with myofibroblastic transdifferentiation. This study, however, does not definitively prove this point given its descriptive nature. Further analyses are required to quantify and validate this point.
In summary, we demonstrate a link between prominin-1 and biliary fibrosis and posit that Prom-1 functionally promotes biliary fibrosis in part through the expansion of profibrogenic ductular reactions. As such, Prom-1-expressing cells or signaling upstream or downstream of Prom-1 could provide potential targets of therapeutic intervention of biliary fibrogenesis.
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